| Millenium Home Health Care, Inc | |
| 370 Reed Road, Suite 319, Broomall, Pennsylvania 19008 | |
| (610) 543-4126 | |
| Name | Millenium Home Health Care, Inc |
|---|---|
| Location | 370 Reed Road, Suite 319, Broomall, Pennsylvania |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 397603 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 18914, 18938, 18940, 18966, 18974, 19001, 19003, 19004, 19006, 19007, 19008, 19010, 19012, 19013, 19014, 19015, 19018, 19020, 19021, 19022, 19023, 19026, 19027, 19031, 19032, 19033, 19034, 19036, 19038, 19041, 19043, 19047, 19050, 19053, 19054, 19056, 19060, 19061, 19063, 19064, 19067, 19072, 19073, 19074, 19075, 19079, 19081, 19082, 19083, 19085, 19086, 19087, 19090, 19094, 19095, 19096, 19102, 19103, 19104, 19106, 19107, 19111, 19114, 19115, 19116, 19118, 19119, 19120, 19121, 19122, 19123, 19124, 19125, 19126, 19127, 19128, 19129, 19130, 19131, 19132, 19133, 19134, 19135, 19136, 19137, 19138, 19139, 19140, 19141, 19142, 19143, 19144, 19145, 19146, 19147, 19148, 19149, 19150, 19151, 19152, 19153, 19154, 19301, 19317, 19333, 19341, 19342, 19348, 19373, 19380, 19382, 19401, 19403, 19405, 19406, 19422, 19425, 19426, 19428, 19438, 19440, 19444, 19446, 19454, 19460, 19462, 19464, 19465, 19468, 19518, 19525 |
| NPI Number | 1134122039 |
| Organization Name | MILLENIUM HOME HEALTH CARE, INC. |
| Doing Business As | AVEANNA HOME HEALTH |
| Address | 1400 N Providence Rd Ste 212, Media, PA 19063 |
| Phone Number | 610-543-4126 |
News Archive
Kyowa Hakko Kirin Co., Ltd., (Headquarters: Chiyoda-ku, Tokyo; president and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") and Syndax Pharmaceuticals, Inc., (Waltham, Mass.; president and CEO: Arlene M. Morris, "Syndax") today jointly announced that the companies have entered into a license agreement for the exclusive rights to develop and commercialize entinostat in Japan and Korea.
The Ebola virus has killed thousands of people in Western Africa between 2014 and 2016. Recently, another outbreak in Congo emerged, killing roughly a thousand people. Now, scientists are a step closer to an Ebola cure, thanks to two new drugs that appear to be highly effective in treating people with the virus.
Using virtual tissue technology, researchers at Indiana University have identified a potential new drug target in the fight against polycystic kidney disease, an illness with no effective FDA-approved treatment that affects 200,000 people per year in the United States.
Scientists at New York University School of Medicine reveal the important role of early experience in shaping neuronal development and brain plasticity in a new study published in the July 14 issue of the journal Nature.
In an effort to determine the vulnerability of affected Gulf Coast communities following last year's BP oil spill,the National Institute of Environmental Health Sciences has awarded a five-year $7.85 million grant to a consortium of university researchers and Gulf Coast community groups led by the University of Texas Medical Branch at Galveston to examine the safety of Gulf seafood and the long-term health of those who consume it.
› Verified 8 days ago
| Quality Rating: |
News Archive
Kyowa Hakko Kirin Co., Ltd., (Headquarters: Chiyoda-ku, Tokyo; president and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") and Syndax Pharmaceuticals, Inc., (Waltham, Mass.; president and CEO: Arlene M. Morris, "Syndax") today jointly announced that the companies have entered into a license agreement for the exclusive rights to develop and commercialize entinostat in Japan and Korea.
The Ebola virus has killed thousands of people in Western Africa between 2014 and 2016. Recently, another outbreak in Congo emerged, killing roughly a thousand people. Now, scientists are a step closer to an Ebola cure, thanks to two new drugs that appear to be highly effective in treating people with the virus.
Using virtual tissue technology, researchers at Indiana University have identified a potential new drug target in the fight against polycystic kidney disease, an illness with no effective FDA-approved treatment that affects 200,000 people per year in the United States.
Scientists at New York University School of Medicine reveal the important role of early experience in shaping neuronal development and brain plasticity in a new study published in the July 14 issue of the journal Nature.
In an effort to determine the vulnerability of affected Gulf Coast communities following last year's BP oil spill,the National Institute of Environmental Health Sciences has awarded a five-year $7.85 million grant to a consortium of university researchers and Gulf Coast community groups led by the University of Texas Medical Branch at Galveston to examine the safety of Gulf seafood and the long-term health of those who consume it.
› Verified 8 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 95.5 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 97.7 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.9 | 99.6 |
| How often the home health team checked patients for depression | 83.1 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 88.3 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 83.6 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 94.5 | 96.4 |
News Archive
Kyowa Hakko Kirin Co., Ltd., (Headquarters: Chiyoda-ku, Tokyo; president and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") and Syndax Pharmaceuticals, Inc., (Waltham, Mass.; president and CEO: Arlene M. Morris, "Syndax") today jointly announced that the companies have entered into a license agreement for the exclusive rights to develop and commercialize entinostat in Japan and Korea.
The Ebola virus has killed thousands of people in Western Africa between 2014 and 2016. Recently, another outbreak in Congo emerged, killing roughly a thousand people. Now, scientists are a step closer to an Ebola cure, thanks to two new drugs that appear to be highly effective in treating people with the virus.
Using virtual tissue technology, researchers at Indiana University have identified a potential new drug target in the fight against polycystic kidney disease, an illness with no effective FDA-approved treatment that affects 200,000 people per year in the United States.
Scientists at New York University School of Medicine reveal the important role of early experience in shaping neuronal development and brain plasticity in a new study published in the July 14 issue of the journal Nature.
In an effort to determine the vulnerability of affected Gulf Coast communities following last year's BP oil spill,the National Institute of Environmental Health Sciences has awarded a five-year $7.85 million grant to a consortium of university researchers and Gulf Coast community groups led by the University of Texas Medical Branch at Galveston to examine the safety of Gulf seafood and the long-term health of those who consume it.
› Verified 8 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 75.4 | 79.6 |
| How often patients got better at getting in and out of bed | 78.3 | 81.1 |
| How often patients got better at bathing | 66.9 | 82.3 |
| How often patients’ breathing improved | 73.9 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 93.6 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 61.4 | 75 |
| How often home health patients had to be admitted to the hospital | 17 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 13.2 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 98.9 | 94 |
News Archive
Kyowa Hakko Kirin Co., Ltd., (Headquarters: Chiyoda-ku, Tokyo; president and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") and Syndax Pharmaceuticals, Inc., (Waltham, Mass.; president and CEO: Arlene M. Morris, "Syndax") today jointly announced that the companies have entered into a license agreement for the exclusive rights to develop and commercialize entinostat in Japan and Korea.
The Ebola virus has killed thousands of people in Western Africa between 2014 and 2016. Recently, another outbreak in Congo emerged, killing roughly a thousand people. Now, scientists are a step closer to an Ebola cure, thanks to two new drugs that appear to be highly effective in treating people with the virus.
Using virtual tissue technology, researchers at Indiana University have identified a potential new drug target in the fight against polycystic kidney disease, an illness with no effective FDA-approved treatment that affects 200,000 people per year in the United States.
Scientists at New York University School of Medicine reveal the important role of early experience in shaping neuronal development and brain plasticity in a new study published in the July 14 issue of the journal Nature.
In an effort to determine the vulnerability of affected Gulf Coast communities following last year's BP oil spill,the National Institute of Environmental Health Sciences has awarded a five-year $7.85 million grant to a consortium of university researchers and Gulf Coast community groups led by the University of Texas Medical Branch at Galveston to examine the safety of Gulf seafood and the long-term health of those who consume it.
› Verified 8 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
Kyowa Hakko Kirin Co., Ltd., (Headquarters: Chiyoda-ku, Tokyo; president and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") and Syndax Pharmaceuticals, Inc., (Waltham, Mass.; president and CEO: Arlene M. Morris, "Syndax") today jointly announced that the companies have entered into a license agreement for the exclusive rights to develop and commercialize entinostat in Japan and Korea.
The Ebola virus has killed thousands of people in Western Africa between 2014 and 2016. Recently, another outbreak in Congo emerged, killing roughly a thousand people. Now, scientists are a step closer to an Ebola cure, thanks to two new drugs that appear to be highly effective in treating people with the virus.
Using virtual tissue technology, researchers at Indiana University have identified a potential new drug target in the fight against polycystic kidney disease, an illness with no effective FDA-approved treatment that affects 200,000 people per year in the United States.
Scientists at New York University School of Medicine reveal the important role of early experience in shaping neuronal development and brain plasticity in a new study published in the July 14 issue of the journal Nature.
In an effort to determine the vulnerability of affected Gulf Coast communities following last year's BP oil spill,the National Institute of Environmental Health Sciences has awarded a five-year $7.85 million grant to a consortium of university researchers and Gulf Coast community groups led by the University of Texas Medical Branch at Galveston to examine the safety of Gulf seafood and the long-term health of those who consume it.
› Verified 8 days ago
The patient survey data of Millenium Home Health Care, Inc is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 88 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 87 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 82 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 86 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 71 | 78 |
News Archive
Kyowa Hakko Kirin Co., Ltd., (Headquarters: Chiyoda-ku, Tokyo; president and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") and Syndax Pharmaceuticals, Inc., (Waltham, Mass.; president and CEO: Arlene M. Morris, "Syndax") today jointly announced that the companies have entered into a license agreement for the exclusive rights to develop and commercialize entinostat in Japan and Korea.
The Ebola virus has killed thousands of people in Western Africa between 2014 and 2016. Recently, another outbreak in Congo emerged, killing roughly a thousand people. Now, scientists are a step closer to an Ebola cure, thanks to two new drugs that appear to be highly effective in treating people with the virus.
Using virtual tissue technology, researchers at Indiana University have identified a potential new drug target in the fight against polycystic kidney disease, an illness with no effective FDA-approved treatment that affects 200,000 people per year in the United States.
Scientists at New York University School of Medicine reveal the important role of early experience in shaping neuronal development and brain plasticity in a new study published in the July 14 issue of the journal Nature.
In an effort to determine the vulnerability of affected Gulf Coast communities following last year's BP oil spill,the National Institute of Environmental Health Sciences has awarded a five-year $7.85 million grant to a consortium of university researchers and Gulf Coast community groups led by the University of Texas Medical Branch at Galveston to examine the safety of Gulf seafood and the long-term health of those who consume it.
› Verified 8 days ago
Millenium Home Health Care, Inc Location: 370 Reed Road, Suite 319, Broomall, Pennsylvania 19008 Ratings: Phone: (610) 543-4126 | |
Accucare Home Nursing Inc Location: 1999 Sproul Road Suite 1, Broomall, Pennsylvania 19008 Ratings: NA Phone: (610) 353-7360 |